Dr Anju Kulkarni is a Consultant Clinical Geneticist who leads the Cancer Genetics service at Guy’s and St Thomas’ NHS Foundation Trust. She also sees patients privately at HCA UK’s London Bridge Hospital, Leaders in Oncology Care (LOC), the Harley Street Clinic, and the Wellington Hospital. Dr Kulkarni serves as an advisor on the HCA Healthcare UK Genomic Review Board, Breast Tumour Board, and Urology Tumour Board.

Dr Kulkarni is one of the few Clinical Geneticists in the UK to have specialist training in both Clinical Genetics and Medical Oncology. This dual expertise provides her with an in-depth understanding of genomics and translational medicine within cancer care. She has a special interest in inherited gene changes that predispose individuals to cancer, genetic counselling, and genomic test interpretation for cancer predisposition. Her areas of expertise include common hereditary cancers such as breast, ovarian, endometrial, prostate, and bowel cancers, as well as dermatological cancer genetics and skin cancer.

Dr Kulkarni is passionate about developing innovative technologies and using digital transformation to improve patient care in the field of genomics. She played a key role in the development of the Cancer Genetics App, now known as QGenome, which helps clinicians assess the risk of hereditary cancers and provides referral guidance. She also contributed to the creation of Nucleus, an online genomics educational platform for healthcare professionals. Dr Kulkarni has a proven track record of establishing policies and guidelines related to cancer genetics, collaborating with a wide range of colleagues across clinical genetics, oncology, and allied healthcare specialties.

Dr Kulkarni continues to contribute significantly to the field of cancer genetics, ensuring that patients receive the best possible care through her clinical expertise and innovative approach.